According to the latest report by IMARC Group, titled, “United States Dry Eye Syndrome Market Size: Industry Trends, Share, Growth, Opportunity and Forecast 2022-2027″, The United States dry eye syndrome market is projected to reach a strong growth during the forecast period (2022-2027)
Dry eye syndrome or keratoconjunctivitis sicca (KCS) refers to a medical condition that causes deficiency of moisture and lubrication on the surface of the infected person’s eyes. It causes burning sensation, redness, itchy eyes, pain, discomfort, and photophobia. It is usually treated by applying artificial tears, medication, performing surgeries, and lacrimal plugs.
Request a Free Sample Report: https://www.imarcgroup.com/united-states-dry-eye-syndrome-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
United States Dry Eye Syndrome Market Trends:
The United States dry eye syndrome market is primarily driven by the excessive usage and prolonged exposure to screens of electronic gadgets, including laptops, smartphones, and television. Besides this, the rising prevalence of health conditions,such ashigh blood pressure and benign prostatic hyperplasia, is increasesthe risk of developing dry eye syndrome across the country. In addition to this, the market is fueled by the rising use of contact lens and changing lifestyles among the population. Moreover, technological advancements in healthcare infrastructure and diagnostic technologies are expected to significantly impact the market growth across the globe.
United States Dry Eye Syndrome Market 2022-2027 Analysis and Segmentation:
The report has segmented the market on the basis on disease type, drug type, product and distribution channel.
Breakup by Disease Type:
- Evaporative Dry Eye Syndrome
- Aqueous Dry Eye Syndrome
Breakup by Drug Type:
- Anti-inflammatory Drugs
- Lubricant Eye Drops
- Autologous Serum Eye Drops
Breakup by Product:
- Liquid Drops
- Gel
- Liquid Wipes
- Eye Ointment
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Breakup by Region:
- Northeast
- Midwest
- South
- West
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/united-states-dry-eye-syndrome-market
If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800